✦ LIBER ✦

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

✍ Scribed by Baron, J. M.; Boster, B. L.; Barnett, C. M.

Book ID: 121724926
Publisher: SAGE Publications
Year: 2014
Tongue: English
Weight: 165 KB
Volume: 21
Category: Article
ISSN: 1078-1552
DOI: 10.1177/1078155214527144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of trastuzumab emt

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

✍ Sandhya Girish; Manish Gupta; Bei Wang; Dan Lu; Ian E. Krop; Charles L. Vogel; H 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 520 KB

FDA Approval: Ado-Trastuzumab Emtansine

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Amiri-Kordestani, L.; Blumenthal, G. M.; Xu, Q. C.; Zhang, L.; Tang, S. W.; Ha, 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 262 KB

Trastuzumab Emtansine (T-DM1): A Novel A

Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer

✍ Howard A. Burris III; Jay Tibbitts; Scott N. Holden; Mark X. Sliwkowski; Gail D. 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 851 KB

Ado-trastuzumab emtansine (T-DM1) in hum

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

✍ Peddi, P. F.; Hurvitz, S. A. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 425 KB

Phase I Study of Trastuzumab-DM1, an HER

Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer

✍ Krop, I. E.; Beeram, M.; Modi, S.; Jones, S. F.; Holden, S. N.; Yu, W.; Girish, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 153 KB

Handbook of Therapeutic Antibodies (Dübe

Handbook of Therapeutic Antibodies (Dübel/Handbook of Therapeutic Antibodies) || Trastuzumab (Herceptin®) and Ado-Trastuzumab Emtansine (Kadcyla®): Treatments for HER2-Positive Breast Cancer

✍ Dübel, Stefan; Reichert, Janice M. 📂 Article 📅 2014 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 174 KB